We are live on ! Find out more
AGN.PRA

Allergan plc
AGN.PRA

Delisted

AGN.PRA was delisted on the 28th of February, 2018.

Back to rankings

1 hedge funds and large institutions have $2.69M invested in Allergan plc in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 90 → 1 (-89)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 90

100% less capital invested

Capital invested by funds: $2.11B → $2.69M (-$2.11B)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

Holders
1
Holders Change
-89
Holders Change %
-98.89%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
90
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PWS
Peloton Wealth Strategists
Indiana
+$9.82M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$322M
2
Franklin Resources
Franklin Resources
California
-$186M
3
Deutsche Bank
Deutsche Bank
Germany
-$176M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$131M
5
WAM
Weiss Asset Management
Massachusetts
-$116M

AGN.PRA Hedge Fund Activity: Q1 2018 in Review

1 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q1 2018, worth a combined $2.69M — down 100% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of AGN.PRA and 1 opened new positions — a net loss of 89 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Peloton Wealth Strategists, opening a new position worth an estimated $9.82M. The largest seller was BlackRock, exiting entirely with an estimated $322M sold.

  • 1 institutional investor held Allergan plc (AGN.PRA) as of Q1 2018, down from 90 in Q4 2017.
  • Funds reported $2.69M of Allergan plc stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Allergan plc positions in Q1 2018 and 90 closed out, a net change of -89 holders.
  • The largest Allergan plc buyer in Q1 2018 was Peloton Wealth Strategists, an estimated $9.82M added.
  • The largest Allergan plc seller in Q1 2018 was BlackRock, an estimated $322M sold.

Based on aggregated 13F filings for Q1 2018.